Aparna Deora

414 total citations
7 papers, 317 citations indexed

About

Aparna Deora is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Aparna Deora has authored 7 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 2 papers in Infectious Diseases and 2 papers in Molecular Biology. Recurrent topics in Aparna Deora's work include HIV Research and Treatment (2 papers), Respiratory viral infections research (2 papers) and Influenza Virus Research Studies (2 papers). Aparna Deora is often cited by papers focused on HIV Research and Treatment (2 papers), Respiratory viral infections research (2 papers) and Influenza Virus Research Studies (2 papers). Aparna Deora collaborates with scholars based in United States, Canada and Japan. Aparna Deora's co-authors include Andrew J. Dannenberg, Jay Patel, Baoheng Du, Jaime L. Masferrer, Anthony M.C. Brown, Lee Ratner, William J. Muller, Clifford A. Hudis, Howard T. Thaler and Louise R. Howe and has published in prestigious journals such as Journal of Virology, Journal of Clinical Microbiology and Virology.

In The Last Decade

Aparna Deora

7 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aparna Deora United States 7 126 120 95 52 46 7 317
Kazuya Mori Japan 10 36 0.3× 25 0.2× 114 1.2× 60 1.2× 6 0.1× 21 329
Iris B. Parr United Kingdom 9 160 1.3× 25 0.2× 152 1.6× 142 2.7× 7 0.2× 17 441
Earl M. Ritzi United States 11 139 1.1× 74 0.6× 151 1.6× 71 1.4× 3 0.1× 24 421
Russell E. McDaniel United States 11 187 1.5× 27 0.2× 170 1.8× 12 0.2× 6 0.1× 15 421
Indira Padmalayam United States 13 41 0.3× 9 0.1× 245 2.6× 25 0.5× 8 0.2× 22 536
Jennifer Kouznetsova United States 8 30 0.2× 165 1.4× 155 1.6× 39 0.8× 3 0.1× 11 569
Gloria A. Murphy United States 11 96 0.8× 19 0.2× 192 2.0× 18 0.3× 10 0.2× 19 351
Louise C. Berger United Kingdom 8 67 0.5× 107 0.9× 92 1.0× 56 1.1× 2 0.0× 9 411
Marie‐Noëlle Brunelle France 10 32 0.3× 15 0.1× 227 2.4× 45 0.9× 9 0.2× 11 710
R. Tal Israel 12 19 0.2× 32 0.3× 186 2.0× 25 0.5× 30 0.7× 15 616

Countries citing papers authored by Aparna Deora

Since Specialization
Citations

This map shows the geographic impact of Aparna Deora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aparna Deora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aparna Deora more than expected).

Fields of papers citing papers by Aparna Deora

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aparna Deora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aparna Deora. The network helps show where Aparna Deora may publish in the future.

Co-authorship network of co-authors of Aparna Deora

This figure shows the co-authorship network connecting the top 25 collaborators of Aparna Deora. A scholar is included among the top collaborators of Aparna Deora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aparna Deora. Aparna Deora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Valliere‐Douglass, John, Lisa A. Marzilli, Aparna Deora, et al.. (2019). Biopharmaceutical Industry Practices for Sequence Variant Analyses of Recombinant Protein Therapeutics. PDA Journal of Pharmaceutical Science and Technology. 73(6). 622–634. 6 indexed citations
2.
McCluskie, Michael J., Ningli Zhang, Michelle Benoit, et al.. (2016). The effect of preexisting anti-carrier immunity on subsequent responses to CRM197or Qb-VLP conjugate vaccines. Immunopharmacology and Immunotoxicology. 38(3). 184–196. 28 indexed citations
3.
Akache, Bassel, Risini D. Weeratna, Aparna Deora, et al.. (2016). Anti-IgE Qb-VLP Conjugate Vaccine Self-Adjuvants through Activation of TLR7. Vaccines. 4(1). 3–3. 22 indexed citations
4.
Huang, Liyun, et al.. (2009). Use of Toll-Like Receptor Assays To Detect and Identify Microbial Contaminants in Biological Products. Journal of Clinical Microbiology. 47(11). 3427–3434. 48 indexed citations
5.
Howe, Louise R., Kotha Subbaramaiah, Jay Patel, et al.. (2002). Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer.. PubMed. 62(19). 5405–7. 177 indexed citations
6.
Deora, Aparna & Lee Ratner. (2001). Viral Protein U (Vpu)-Mediated Enhancement of Human Immunodeficiency Virus Type 1 Particle Release Depends on the Rate of Cellular Proliferation. Journal of Virology. 75(14). 6714–6718. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026